Silu Yang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
-
- Neurogenesis and neuroplasticity mechanisms
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 8
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Stephanie A. Herrlinger (2 shared papers)Fan Lai (2 shared papers)Jian-Fu Chen (2 shared papers)Melinda Ann Brindley (1 shared paper)Qiang Shao (1 shared paper)Julie M. Moore (1 shared paper)Ye Shen (1 shared paper)Ying Wang (1 shared paper)
- Journals
- Advances in Therapy (2 papers)Digital Signal Processing (1 paper)Gynecologic Oncology (1 paper)British Journal of Cancer (1 paper)Theoretical Computer Science (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Silu Yang
16 papers receiving 616 citations
Silu Yang's Hit Papers
Peers
Comparison fields: 5 of 51
- Oncology 188
- Developmental Neuroscience 19
- Pulmonary and Respiratory Medicine 142
- Otorhinolaryngology 22
- Public Health, Environmental and Occupational Health 129
Countries citing papers authored by Silu Yang
This map shows the geographic impact of Silu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silu Yang more than expected).
Fields of papers citing papers by Silu Yang
This network shows the impact of papers produced by Silu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silu Yang. The network helps show where Silu Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Silu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial Hit paper breakdown → | 2024 | 186 |
| 2 | 2016 | 171 | |
| 3 | 2020 | 120 | |
| 4 | 2009 | 54 | |
| 5 | 2015 | 36 | |
| 6 | 2025 | 13 | |
| 7 | 2022 | 12 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 9 | |
| 10 | 2025 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2014 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2025 | 1 |
About Silu Yang
Silu Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Developmental Neuroscience, Obstetrics and Gynecology and Immunology, having authored 16 papers that have together received 630 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Gastric Cancer Management and Outcomes (3 papers), Epigenetics and DNA Methylation (1 paper), Genomics and Chromatin Dynamics (1 paper), Enhanced Recovery After Surgery (1 paper), T-cell and B-cell Immunology (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper) and Mosquito-borne diseases and control (1 paper). The work is most often cited by research in Oncology (188 citations), Developmental Neuroscience (19 citations), Pulmonary and Respiratory Medicine (142 citations), Otorhinolaryngology (22 citations) and Public Health, Environmental and Occupational Health (129 citations). Silu Yang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Stephanie A. Herrlinger, Fan Lai, Jian-Fu Chen, Melinda Ann Brindley, Qiang Shao, Julie M. Moore, Ye Shen, Ying Wang, Qun He and Jiyong Wang. Their work appears in journals such as Advances in Therapy, Digital Signal Processing, Gynecologic Oncology, British Journal of Cancer and Theoretical Computer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.